IBDEI0HV ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8685,1,3,0)
 ;;=3^Oth Plastic Surgery
 ;;^UTILITY(U,$J,358.3,8685,1,4,0)
 ;;=4^V50.1
 ;;^UTILITY(U,$J,358.3,8685,2)
 ;;=^87802
 ;;^UTILITY(U,$J,358.3,8686,0)
 ;;=368.8^^58^613^39
 ;;^UTILITY(U,$J,358.3,8686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8686,1,3,0)
 ;;=3^Oth Specific Visual Disturbances
 ;;^UTILITY(U,$J,358.3,8686,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,8686,2)
 ;;=^88172
 ;;^UTILITY(U,$J,358.3,8687,0)
 ;;=368.13^^58^613^40
 ;;^UTILITY(U,$J,358.3,8687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8687,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,8687,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,8687,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,8688,0)
 ;;=998.59^^58^613^41
 ;;^UTILITY(U,$J,358.3,8688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8688,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,8688,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,8688,2)
 ;;=^97081
 ;;^UTILITY(U,$J,358.3,8689,0)
 ;;=368.03^^58^613^5
 ;;^UTILITY(U,$J,358.3,8689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8689,1,3,0)
 ;;=3^Amblyopia,Refractive
 ;;^UTILITY(U,$J,358.3,8689,1,4,0)
 ;;=4^368.03
 ;;^UTILITY(U,$J,358.3,8689,2)
 ;;=^265363
 ;;^UTILITY(U,$J,358.3,8690,0)
 ;;=367.31^^58^613^6
 ;;^UTILITY(U,$J,358.3,8690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8690,1,3,0)
 ;;=3^Anisometropia
 ;;^UTILITY(U,$J,358.3,8690,1,4,0)
 ;;=4^367.31
 ;;^UTILITY(U,$J,358.3,8690,2)
 ;;=^7839
 ;;^UTILITY(U,$J,358.3,8691,0)
 ;;=367.20^^58^613^7
 ;;^UTILITY(U,$J,358.3,8691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8691,1,3,0)
 ;;=3^Astigmatism,NOS
 ;;^UTILITY(U,$J,358.3,8691,1,4,0)
 ;;=4^367.20
 ;;^UTILITY(U,$J,358.3,8691,2)
 ;;=^11141
 ;;^UTILITY(U,$J,358.3,8692,0)
 ;;=367.0^^58^613^31
 ;;^UTILITY(U,$J,358.3,8692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8692,1,3,0)
 ;;=3^Hypermetropia
 ;;^UTILITY(U,$J,358.3,8692,1,4,0)
 ;;=4^367.0
 ;;^UTILITY(U,$J,358.3,8692,2)
 ;;=^60139
 ;;^UTILITY(U,$J,358.3,8693,0)
 ;;=367.1^^58^613^36
 ;;^UTILITY(U,$J,358.3,8693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8693,1,3,0)
 ;;=3^Myopia
 ;;^UTILITY(U,$J,358.3,8693,1,4,0)
 ;;=4^367.1
 ;;^UTILITY(U,$J,358.3,8693,2)
 ;;=^80671
 ;;^UTILITY(U,$J,358.3,8694,0)
 ;;=V43.1^^58^613^44
 ;;^UTILITY(U,$J,358.3,8694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8694,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,8694,1,4,0)
 ;;=4^V43.1
 ;;^UTILITY(U,$J,358.3,8694,2)
 ;;=^69114
 ;;^UTILITY(U,$J,358.3,8695,0)
 ;;=367.9^^58^613^46
 ;;^UTILITY(U,$J,358.3,8695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8695,1,3,0)
 ;;=3^Refractive Error
 ;;^UTILITY(U,$J,358.3,8695,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,8695,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,8696,0)
 ;;=365.04^^58^613^26
 ;;^UTILITY(U,$J,358.3,8696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8696,1,3,0)
 ;;=3^Glaucoma Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,8696,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,8696,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,8697,0)
 ;;=365.01^^58^613^30
 ;;^UTILITY(U,$J,358.3,8697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8697,1,3,0)
 ;;=3^Glaucoma Suspect
 ;;^UTILITY(U,$J,358.3,8697,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,8697,2)
 ;;=^340633
 ;;^UTILITY(U,$J,358.3,8698,0)
 ;;=365.71^^58^613^24
 ;;^UTILITY(U,$J,358.3,8698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8698,1,3,0)
 ;;=3^Glaucoma Mild Stage
 ;;^UTILITY(U,$J,358.3,8698,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,8698,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,8699,0)
 ;;=365.72^^58^613^25
 ;;^UTILITY(U,$J,358.3,8699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8699,1,3,0)
 ;;=3^Glaucoma Moderate Stage
